Empyrean Technology Co Ltd (301269) Report Interpretation

Overview

This risk-reward update incorporates Empyrean's 2Q26 results. Morgan Stanley retains its Equal-weight rating and Rmb95 target, balancing the company's role in China's EDA localization and expected above-industry growth against higher near-term R&D costs, customer concentration, execution uncertainty and a valuation it considers fair.

Core views

Morgan Stanley updates its model for Empyrean Technology after 2Q26 actual results. The principal earnings change is an 8% reduction in 2026e EPS, to Rmb0.39 from Rmb0.43, driven mainly by higher R&D expense. Its 2027e and 2028e EPS estimates remain largely unchanged at Rmb1.02 and Rmb1.72, respectively, and the institution retains both an Equal-weight rating and a Rmb95 price target. The Rmb92.47 closing share price on September 3, 2026 was cited alongside the target. The long-term thesis rests on Empyrean's position as China's largest local EDA vendor by 2025 sales and its potential role in semiconductor localization. Morgan Stanley expects 23% revenue CAGR over 2025-28e, above the industry's stated 10-12% growth. In the base case, Empyrean is expected to achieve digital IC full-flow EDA by 2027 and expand its share of China's EDA market to 16% by 2030. The earnings inputs point to growth accelerating across the business: digital EDA revenue growth is projected at 15.7% in 2026e, 25.0% in 2027e and 30.0% in 2028e; analog EDA is projected to grow 10.6%, 10.0% and 10.0%; and foundry EDA 44.2%, 42.0% and 50.0%. The risk-reward cases are defined chiefly by execution in digital IC and foundry EDA, and the resulting market-share trajectory. The bull case assumes 30% revenue CAGR in 2025-28e, digital IC and foundry full-flow EDA by 2026, and China EDA share above 20% by 2030, with a Rmb130 value based on 44x 2026e P/S. The base case uses a Rmb95 value and 32x 2026e P/S, alongside a residual-income valuation that assumes an 8% cost of equity, comprising a 2% risk-free rate, 5% risk premium and 1.20 beta, plus medium-term and terminal growth assumptions of 25% and 7%. The bear case assumes only 10% revenue CAGR, limited digital IC and foundry EDA breakthroughs by 2026, market share stagnating near 10% by 2030, and Rmb55 based on 19x 2026e P/S. Morgan Stanley considers the current 31x 2026e P/S valuation fair, although it is stated to be two to three times that of global peers that grow broadly in line with industry growth. The report therefore presents a neutral relative-rating stance: secular localization potential and successful technology milestones could improve the outcome, but high customer concentration may continue to cause quarterly volatility. The named upside catalysts are faster-than-expected full-flow digital IC EDA progress, fewer restrictions on China's access to semiconductor equipment and a larger local EDA talent pool. Downside risks are slower-than-expected digital IC EDA progress, tighter restrictions on equipment access and a shortage of local EDA talent.

Analysis framework

Morgan Stanley first updates earnings estimates using reported 2Q26 results and higher R&D expense, then evaluates medium-term revenue growth and EDA technology milestones by business segment. It frames valuation through bull, base and bear scenarios using 2026e P/S multiples, while deriving the base-case value from a residual-income model and testing outcomes against assumptions for growth, market share, cost of equity and technology execution.

Methodology notes

• Valuation methodsRIM (Residual Income Model)

  Residual income model

  The report derives its base-case value from residual income, using an 8% cost of equity and explicit medium-term and terminal growth assumptions.

• Valuation methodsPS valuation

  Price-to-sales scenario valuation

  Bull, base and bear values are paired with 2026e P/S multiples of 44x, 32x and 19x to show how different growth and execution outcomes affect valuation.

• Industry AnalysisUpstream-Midstream-Downstream Transmission

  EDA technology and semiconductor-localization transmission

  The report links progress in digital IC and foundry EDA, local customer capability, equipment access and talent availability to Empyrean's market share and revenue growth.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Empyrean Technology Co Ltd (301269.SZ)

  Primary covered company and China EDA localization beneficiary.

  Strengths

  China's largest local EDA vendor by 2025 sales; expected 23% revenue CAGR in 2025-28e and potential market-share expansion.

  Weaknesses

  Higher R&D expense reduces 2026e EPS, while customer concentration may sustain quarterly-result volatility.

  Comparison

  Its 31x 2026e P/S valuation is stated to be two to three times global peers, which are expected to grow in line with industry growth.

  Risks

  Slower EDA technology breakthroughs, tighter semiconductor-equipment restrictions and insufficient local EDA talent.

Key data

• 2026e EPSRmb0.39Reduced from prior Rmb0.43, an 8% cut mainly because of higher R&D expense.
• 2027e EPSRmb1.02Largely unchanged.
• 2028e EPSRmb1.72Largely unchanged.
• Price targetRmb95.00Maintained.
• Share priceRmb92.47Closing price on September 3, 2026.
• Base-case revenue CAGR23%Morgan Stanley estimate for 2025-28e, compared with 10-12% industry growth.
• Base-case China EDA market share16%Expected by 2030.
• Current valuation31x 2026e P/SDescribed as fair and two to three times global-peer valuation.

Impact & implications

The report's maintained target and Equal-weight rating indicate that the higher 2026 R&D burden does not alter Morgan Stanley's medium-term growth view. However, the firm sees the current valuation as already fair, making future outcomes especially dependent on digital IC and foundry EDA execution, market-share gains and the external environment for China's semiconductor ecosystem.

Risks

• Customer concentration may remain high in the near term, increasing volatility in quarterly results.
• A slower-than-expected full-flow digital IC EDA breakthrough could weaken growth and valuation outcomes.
• More restrictions on China's access to semiconductor equipment could constrain the localization thesis.
• A drought in the local EDA talent pool could hinder execution.

What to watch

• Progress toward full-flow digital IC EDA and foundry EDA milestones.
• Revenue growth across digital, analog and foundry EDA segments.
• Empyrean's China EDA market-share trajectory toward the base-case 16% by 2030.
• Changes in semiconductor-equipment access, government support and local EDA talent availability.